EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NVAX) Stock Revalued After Pivot To Sanofi Deal And Matrix M Licensing Model
Novavax (NASDAQ:NVAX) Given Buy Rating at BTIG Research - Daily Political
Critical Contrast: DNAPrint Genomics (OTCMKTS:DNAG) and Novavax (NASDAQ:NVAX) - Markets Daily
Novavax Pivots To Matrix M Licensing As Sanofi Takes Europe
Is Novavax (NVAX) Trading Near Fair Value As It Pivots Toward Royalties And Licensing?
Novavax (NASDAQ:NVAX) Trading Down 6.2% - Should You Sell? - Daily Political
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Novavax (NASDAQ:NVAX) Trading Down 7.3% - Here's Why - Stock Observer
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Zolmax
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Daily Political
Zacks Research Has Positive Outlook for Novavax Q2 Earnings - Stock Observer
Why Novavax (NVAX) Stock Is Trading Up Today
Novavax (NASDAQ:NVAX) Stock Price Up 11.6% - What's Next? - Daily Political
The Bull Case For Novavax (NVAX) Could Change Following Shah Capital's Activist Governance Challenge - Learn Why
Assessing Novavax (NVAX) Valuation As Shah Capital Challenges Leadership And Sanofi Partnership
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
The Top 5 Analyst Questions From Novavax's Q1 Earnings Call
Are Novavax's (NVAX) Activist Pressure and Partnership Pivot Quietly Rewriting Its Investment Narrative?
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
